Integer to Showcase European Expansion, Commitment to Medical Device OEMs and Start-Ups at Compamed 2023

Rhea-AI Summary

Integer Holdings Corporation (NYSE: ITGR) to showcase its expansion in Europe at Compamed 2023, focusing on significant investments in Ireland. The company aims to connect with medical device OEMs and start-ups to discuss its suite of solutions, including prototype and pilot services. Integer has recently expanded its site in New Ross, Ireland, and invested in a new R&D and manufacturing facility in Galway, Ireland, to enhance its manufacturing capacity and provide local solutions for various medical applications.

Positive

• Integer's strategic expansion in Ireland demonstrates its commitment to strengthening its R&D and manufacturing capabilities, which can lead to accelerated time to market for new product innovations.

Negative

• None.

PLANO, Texas, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer and a complete partner in innovation, will exhibit at Compamed 2023 from November 13-16, in Düsseldorf, Germany. Integer can be found in Hall 8b / N29.

During Compamed, Integer looks forward to connecting with medical device OEMs and start-ups to discuss its comprehensive suite of solutions from prototype to pilot and beyond. Integer’s focal points for Compamed 2023 revolve around the company’s significant investments in Europe, particularly in Ireland.

Integer has recently undertaken a strategic expansion of its site in New Ross, Ireland, covering an additional 80,000 square feet to substantially increase its high-volume guidewire and wire-based manufacturing capacity. Alongside the New Ross expansion, Integer has also invested in a new R&D and manufacturing facility in Galway, Ireland. The first construction phase of this new facility will add approximately 70,000 square feet of R&D and manufacturing space. This expansion aims to provide local solutions for structural heart, neurovascular, and electrophysiology applications, enabling seamless transitions from R&D to operations.

Further amplifying the company’s presence in Ireland, Integer’s team of experts in Spiddal, Ireland, specializes in complex braiding, textile, and impact coating and covering capabilities. The team offers comprehensive solutions, including medical textiles, absorbable stents, and biomaterial braiding, among others.

“We are committed to delivering unparalleled value to our partners,” said Payman Khales, President, Cardio & Vascular. “With our recent expansions in Europe, we’re dramatically strengthening our local and global differentiated R&D and manufacturing capabilities. Our aim is to streamline the supply chain and ensure a smooth transition from R&D to operations for both our European and global customers, helping to accelerate time to market for new product innovations.”

Medical device OEMs, start-ups and all interested parties are invited to visit Hall 8b / N29 during Compamed from November 13-16, 2023, to learn more about how Integer can serve as your complete partner in innovation.

Learn more about Integer at www.integer.net.

About Integer^®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular, portable medical and orthopedics markets. The Company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, the Company develops batteries for high-end niche applications in energy, military, and environmental markets. The Company's brands include Greatbatch Medical^®, Lake Region Medical^® and Electrochem^®. Additional information is available at www.integer.net

Investor Relations: Andrew Senn andrew.senn@integer.net 763.951.8312

Media Relations: Kelly Butler kelly.butler@integer.net 214.618.4216

FAQ

What is Integer Holdings Corporation (NYSE: ITGR) showcasing at Compamed 2023?

Integer is showcasing its significant investments in Europe, particularly in Ireland, and its suite of solutions for medical device OEMs and start-ups, including prototype and pilot services.

What recent expansions has Integer undertaken in Ireland?

Integer has expanded its site in New Ross, Ireland, and invested in a new R&D and manufacturing facility in Galway, Ireland, to enhance its manufacturing capacity and provide local solutions for various medical applications.

What is the aim of Integer's expansion in Europe?

The aim of Integer's expansion in Europe is to streamline the supply chain and ensure a smooth transition from R&D to operations for both European and global customers, accelerating time to market for new product innovations.